DD283934A5 - Intravenoes anwendbare pharmazeutische praeparate und verfahren zu ihrer herstellung - Google Patents

Intravenoes anwendbare pharmazeutische praeparate und verfahren zu ihrer herstellung Download PDF

Info

Publication number
DD283934A5
DD283934A5 DD89331046A DD33104689A DD283934A5 DD 283934 A5 DD283934 A5 DD 283934A5 DD 89331046 A DD89331046 A DD 89331046A DD 33104689 A DD33104689 A DD 33104689A DD 283934 A5 DD283934 A5 DD 283934A5
Authority
DD
German Democratic Republic
Prior art keywords
preparation
cyclosporin
mixture
monoesters
polyethylene glycol
Prior art date
Application number
DD89331046A
Other languages
German (de)
English (en)
Inventor
Ernoe Orban
Tibor Balogh
Lajos Ila
Gabor Ambrus
Antonia Jekkel
Sandor Elek
Eva Tomori
Lajos Siklosi
Sarudy Eva Toth
Imre Moravcsik
Original Assignee
�����@������������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �����@������������������k�� filed Critical �����@������������������k��
Publication of DD283934A5 publication Critical patent/DD283934A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD89331046A 1988-07-21 1989-07-21 Intravenoes anwendbare pharmazeutische praeparate und verfahren zu ihrer herstellung DD283934A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU883796A HU201567B (en) 1988-07-21 1988-07-21 Process for production of intravenous medical compositions containing cyclosphorin

Publications (1)

Publication Number Publication Date
DD283934A5 true DD283934A5 (de) 1990-10-31

Family

ID=10965544

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89331046A DD283934A5 (de) 1988-07-21 1989-07-21 Intravenoes anwendbare pharmazeutische praeparate und verfahren zu ihrer herstellung

Country Status (26)

Country Link
US (1) US5047396A (it)
JP (1) JPH07116051B2 (it)
KR (1) KR0137674B1 (it)
AR (1) AR243382A1 (it)
AT (1) AT402258B (it)
AU (1) AU614862B2 (it)
BE (1) BE1004323A4 (it)
CA (1) CA1332712C (it)
CH (1) CH679120A5 (it)
DD (1) DD283934A5 (it)
DE (1) DE3924207A1 (it)
DK (1) DK175540B1 (it)
FI (1) FI92556C (it)
FR (1) FR2635265B1 (it)
GB (1) GB2221157B (it)
GR (1) GR1002184B (it)
HU (1) HU201567B (it)
IL (1) IL91069A (it)
IT (1) IT1231434B (it)
LU (1) LU87560A1 (it)
NL (1) NL194578C (it)
NO (1) NO175287C (it)
NZ (1) NZ230036A (it)
PT (1) PT91246B (it)
SE (1) SE509174C2 (it)
ZA (1) ZA895588B (it)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GB2251186A (en) * 1990-12-04 1992-07-01 Randall Neal Gatz Polypeptide for use in treatment of autoimmune disease
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
WO1993023010A1 (en) * 1992-05-13 1993-11-25 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
DE4412201A1 (de) * 1993-04-20 1994-11-10 Rentschler Arzneimittel Neue pharmazeutische Zubereitungen zur oralen Verabreichung enthaltend Cyclosporin
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US20020099067A1 (en) * 1993-07-08 2002-07-25 Ulrich Posanski Pharmaceutical compositions for sparingly soluble therapeutic agents
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
KR0146671B1 (ko) * 1994-02-25 1998-08-17 김충환 사이클로스포린-함유 분말 조성물
EP0789580B1 (de) * 1994-11-03 2002-06-05 Novartis AG Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
AU709548B2 (en) * 1995-08-25 1999-09-02 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US20050053594A1 (en) * 1995-11-16 2005-03-10 Dario Alessi RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK
DE19544507B4 (de) * 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
ES2229473T3 (es) 1997-01-30 2005-04-16 Novartis Ag Composiciones farmaceuticas sin aceite que contienen ciclosporina a.
IL131609A0 (en) * 1997-03-12 2001-01-28 Abbott Lab Hydrophilic binary systems for the administration of cyclosporine
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
AT408186B (de) * 1998-12-15 2001-09-25 Sanochemia Pharmazeutika Ag Wässerige zubereitung von beta-carotin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
DE10015814A1 (de) * 2000-03-30 2001-10-11 Max Planck Gesellschaft Arzneimittel zur Stimulierung der Leukopoese, zur Behandlung von Tumor- und Protozoenerkrankungen und Verfahren zu seiner Herstellung
FR2826517B1 (fr) * 2001-06-20 2004-03-12 Somfy Dispositif d'alimentation pour store motorise ou similaire
JP2005506990A (ja) * 2001-10-19 2005-03-10 アイソテクニカ インコーポレーテッド 新規のシクロスポリン類似体のマイクロエマルションプレコンセントレート
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7288520B2 (en) 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) * 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) * 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
GB2451811A (en) 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
JP4815418B2 (ja) * 2007-10-19 2011-11-16 カヤバ工業株式会社 空圧緩衝器
BRPI0918253A2 (pt) * 2008-09-12 2015-12-15 Critical Pharmaceuticals Ltd aperfeicoamento na absorcao de agentes terapeuticos atraves das membranas mucosas ou da pele
FR2948568B1 (fr) * 2009-07-30 2012-08-24 Sanofi Aventis Formulation pharmaceutique
AU2012229236B2 (en) 2011-03-11 2017-05-18 Beth Israel Deaconess Medical Center, Inc. Anti-CD40 antibodies and uses thereof
AU2016315873B2 (en) 2015-09-04 2022-08-18 Primatope Therapeutics Inc. Humanized anti-CD40 antibodies and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3658M (fr) * 1964-02-18 1965-11-02 Michel Marie Andre Guerbet Composition huileuse pour l'injection intravasculaire.
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
AU534955B2 (en) * 1980-01-23 1984-02-23 Sandoz Ag Cyclosporin a to treat lymphoproliferative disorders
DE3339235A1 (de) * 1983-10-28 1985-05-09 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von polyurethanen
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
JPH02501389A (ja) * 1987-10-02 1990-05-17 フセソユズニ　カルディオロジチェスキ　ナウチニ　ツェントル　アカデミイ　メディツィンスキフ　ナウク　エスエスエスエル 多発性硬化症及び筋萎縮側索硬化症の治療用薬用製剤
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
US4943560A (en) * 1988-04-06 1990-07-24 Regents Of The University Of Minnesota Solvent system for chronic vascular infusion of hydrophobic drugs
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
SE509174C2 (sv) 1998-12-14
AU3884589A (en) 1990-02-01
IL91069A (en) 1993-07-08
NO892995L (no) 1990-01-22
FI893520A (fi) 1990-01-22
FR2635265A1 (fr) 1990-02-16
PT91246A (pt) 1990-02-08
DK362189D0 (da) 1989-07-21
PT91246B (pt) 1995-05-04
NO175287B (no) 1994-06-20
GB2221157A (en) 1990-01-31
LU87560A1 (fr) 1991-02-18
NO892995D0 (no) 1989-07-21
NL194578C (nl) 2002-08-05
DE3924207C2 (it) 1992-07-09
GR890100467A (el) 1990-06-27
CA1332712C (en) 1994-10-25
CH679120A5 (it) 1991-12-31
BE1004323A4 (fr) 1992-11-03
DE3924207A1 (de) 1990-01-25
AT402258B (de) 1997-03-25
DK175540B1 (da) 2004-11-29
GB2221157B (en) 1991-12-18
DK362189A (da) 1990-01-22
FI92556B (fi) 1994-08-31
IT8921259A0 (it) 1989-07-21
GB8916679D0 (en) 1989-09-06
GR1002184B (en) 1996-03-12
HU201567B (en) 1990-11-28
KR0137674B1 (ko) 1998-05-15
HUT50851A (en) 1990-03-28
AR243382A1 (es) 1993-08-31
SE8902588D0 (sv) 1989-07-21
NL194578B (nl) 2002-04-02
IT1231434B (it) 1991-12-04
ZA895588B (en) 1990-07-25
NO175287C (no) 1994-09-28
KR900001364A (ko) 1990-02-27
US5047396A (en) 1991-09-10
FI92556C (fi) 1994-12-12
ATA176789A (de) 1996-08-15
NZ230036A (en) 1991-02-26
JPH07116051B2 (ja) 1995-12-13
NL8901902A (nl) 1990-02-16
FR2635265B1 (fr) 1995-03-17
JPH03115227A (ja) 1991-05-16
SE8902588L (sv) 1990-01-22
FI893520A0 (fi) 1989-07-21
AU614862B2 (en) 1991-09-12

Similar Documents

Publication Publication Date Title
DD283934A5 (de) Intravenoes anwendbare pharmazeutische praeparate und verfahren zu ihrer herstellung
DE69328829T2 (de) Rapamycin formulierung zur iv-injektion
DE69413921T2 (de) Rapamycin-Zubereitungen für die intravenöse Injektion
DE4340781C3 (de) Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
DE69413923T2 (de) Rapamycin-Zubereitungen für die intravenöse Injektion
DE19544507B4 (de) Cyclosporin enthaltende Präparate
DE69325256T2 (de) Insizierbare lecithin gel
DE69734742T2 (de) Arzneizusammensetzungen enthaltend Ascomycinderivate
DE69328192T2 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
DE69825137T2 (de) Liposomale Erythropoietin-Dispersion
AT395819B (de) Wasserloesliche monoester als solubilisatoren fuer pharmakologische wirkstoffe und pharmazeutische hilfsstoffe
DE60308888T2 (de) Injizierbare 2,6-diisopropylphenol enthaltende anästhetische zusammensetzung und verfahren
DE68903814T2 (de) Etoposid-loesungen.
DE69414810T2 (de) Rapamycin-Zubereitungen zur oralen Verabreichung
DE69428967T2 (de) Pharmazeutische emulsionen, die bioaktive steroide enthalten
EP2142169B1 (de) Wässrige pharmazeutische zubereitung
WO2017015690A1 (de) Konzentrat enthaltend alprostadil
DE69426295T2 (de) Organkonservierungsmittel
DE3830494B4 (de) Wasserlösliche Monoester als Solubilisatoren für pharmakologische Wirkstoffe und pharmazeutische Hilfsstoffe
DE10323279A1 (de) Gebrauchsfertige Gemcitabin-Lösungen
EP1309353B1 (de) Flavonhaltige pflanzenextraktlösungen mit verbesserter lager- und hitzestabilität
EP3328358A1 (de) Konzentrat enthaltend alprostadil
DE10323278A1 (de) Gebrauchsfertige Gemcitabin-Lösungskonzentrate
DE10142418A1 (de) Arzneimittel
DE10142417A1 (de) Arzneimittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee